On July 19, 2018,SungenBio participated in BIO TAIWAN, bringing a variety of ingredients such as natural vitamin K2 (MK-7), nattokinase, γ-polyglutamic acid and hirudin. It has reached a number of trade agreements and research cooperation intentions with multinational enterprises and research institutions in Asia, Europe and the United States.

At the same time,SungenBio held a special presentation on vitamin K2 and nattokinase. Dr. Chen Jiepeng, the chief scientist of Shuangjun Bio, Professor Zhang Meixia from China Medical University and Professor Xu Feng from Shenyang Pharmaceutical University delivered special speeches.They showed the latest achievements in the research of SungenBio peptide drugs and bio-fermentation technology and introduced the mechanism of vitamin K2.In addition,a real-world RWS study of 2000 cases of nattokinase thrombolytic effect was shared.